EFFICACY OF ORAL FLUOROQUINOLONES VERSUS CONVENTIONAL INTRAVENOUS ANTIPSEUDOMONAL CHEMOTHERAPY IN TREATMENT OF CYSTIC-FIBROSIS

被引:34
作者
JENSEN, T [1 ]
PEDERSEN, SS [1 ]
HOIBY, N [1 ]
KOCH, C [1 ]
机构
[1] RIGSHOSP,STATENS SERUMINST,DEPT CLIN MICROBIOL,DK-2200 COPENHANGEN,DENMARK
关键词
D O I
10.1007/BF02013055
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:618 / 622
页数:5
相关论文
共 20 条
[1]   ANTIMICROBIAL ACTIVITY OF CIPROFLOXACIN AGAINST PSEUDOMONAS-AERUGINOSA, ESCHERICHIA-COLI, AND STAPHYLOCOCCUS-AUREUS DETERMINED BY THE KILLING CURVE METHOD - ANTIBIOTIC COMPARISONS AND SYNERGISTIC INTERACTIONS [J].
CHALKLEY, LJ ;
KOORNHOF, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :331-342
[2]  
CHAPMAN ST, 1985, LANCET, V2, P39
[3]  
CHERNY FJ, 1984, AM J DISEASES CHILDR, P261
[4]   CIPROFLOXACIN IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC-BRONCHITIS [J].
DAVIES, BI ;
MAESEN, FPV ;
BAUR, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :226-231
[5]  
HODSON ME, 1987, LANCET, V1, P235
[6]  
HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65
[7]  
HOIBY N, 1982, ACTA PAEDIATR SC S, V301, P75
[8]   PHARMACOKINETICS AND PHARMACODYNAMICS OF CIPROFLOXACIN IN CYSTIC-FIBROSIS PATIENTS [J].
LEBEL, M ;
BERGERON, MG ;
VALLEE, F ;
FISET, C ;
CHASSE, G ;
BIGONESSE, P ;
RIVARD, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :260-266
[9]   DOES CENTRALIZED TREATMENT OF CYSTIC-FIBROSIS INCREASE THE RISK OF PSEUDOMONAS-AERUGINOSA INFECTION [J].
PEDERSEN, SS ;
JENSEN, T ;
PRESSLER, T ;
HOIBY, N ;
ROSENDAL, K .
ACTA PAEDIATRICA SCANDINAVICA, 1986, 75 (05) :840-845
[10]   AZLOCILLIN COMPARED WITH CARBENICILLIN IN THE TREATMENT OF BRONCHOPULMONARY INFECTION DUE TO PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS [J].
PENKETH, A ;
HODSON, ME ;
GAYA, H ;
BATTEN, JC .
THORAX, 1984, 39 (04) :299-304